From: Protective effect of 6-paradol in acetic acid-induced ulcerative colitis in rats
Parameter | Group [Mean ± SEM (95%CI)]; Mean Rank (Italics) | Kruskal-Wallis H | p | |||||
---|---|---|---|---|---|---|---|---|
Normal Control (NC) | Acetic acid induced colitis: Untreated (AC) | Sulfasalazine treated (500 mg/kg) (SG) | 6-paradol (50 mg/kg) (LT) | 6-paradol (100 mg/kg) (MT) | 6-paradol (200 mg/kg) (HT) | |||
Colonic MPOa,b (unit/g) | 12.28 ± 0.44 (11.24, 13.32) | 49.80 ± 1.61 (45.97, 53.62) | 16.020 ± 0.66 (14.61, 17.78) | 41.56 ± 1.14 (38.85, 44.26) | 26.26 ± 0.88 (24.16, 28.35) | 17.58 ± 0.75 (15.80, 19.37) | 44.35 | 0.001 |
4.50 | 44.00 | 14.81 | 37.00 | 28.50 | 18.19 | |||
Colonic MDAa,b (mmol/mg) | 16.90 ± 0.49 (15.73, 18.06) | 44.20 ± 1.68 (40.20, 48.19) | 17.57 ± 0.77 (15.74, 19.40) | 36.17 ± 0.81 (34.25, 38.09) | 25.57 ± 0.88 (23.49, 27.65) | 18.27 ± 0.98 (15.95, 20.59) | 40.46 | 0.001 |
10.56 | 44.13 | 12.81 | 36.88 | 28.44 | 14.19 | |||
Serum IL-6a,b,c (pg/ml) | 12.01 ± 0.31 (11.25, 12.74) | 41.53 ± 1.11 (38.90, 44.16) | 12.93 ± 0.40 (11.98, 13.89) | 35.57 ± 1.54 (31.92, 39.22) | 25.86 ± 0.74 (24.11, 27.61) | 14.71 ± 0.78 (12.85, 16.56) | 42.30 | 0.001 |
7.19 | 43.75 | 12.25 | 37.00 | 28.75 | 18.06 | |||
Serum MDAa,b,c (nmol/l) | 21.96 ± 0.75 (20.17, 23.75) | 84.35 ± 2.03 (79.53, 89.16) | 22.27 ± 0.66 (20.70, 23.84) | 68.61 ± 1.76 (64.43, 72.78) | 47.50 ± 2.29 (42.07, 52.92) | 26.61 ± 0.85 (24.59, 28.62) | 43.23 | 0.001 |
9.31 | 44.25 | 8.81 | 36.75 | 28.50 | 19.38 |